JP2017504576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017504576A5 JP2017504576A5 JP2016536162A JP2016536162A JP2017504576A5 JP 2017504576 A5 JP2017504576 A5 JP 2017504576A5 JP 2016536162 A JP2016536162 A JP 2016536162A JP 2016536162 A JP2016536162 A JP 2016536162A JP 2017504576 A5 JP2017504576 A5 JP 2017504576A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- acetamide
- hydroxypropan
- hexafluoro
- cyclopropylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13195813.4 | 2013-12-05 | ||
| EP13195813 | 2013-12-05 | ||
| EP14183274.1 | 2014-09-02 | ||
| EP14183274 | 2014-09-02 | ||
| PCT/EP2014/076390 WO2015082533A1 (en) | 2013-12-05 | 2014-12-03 | Ror gamma (rory) modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017504576A JP2017504576A (ja) | 2017-02-09 |
| JP2017504576A5 true JP2017504576A5 (enExample) | 2018-12-27 |
| JP6461960B2 JP6461960B2 (ja) | 2019-01-30 |
Family
ID=52021176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016536162A Expired - Fee Related JP6461960B2 (ja) | 2013-12-05 | 2014-12-03 | ＲＯＲガンマ（γ）モジュレータ |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9738600B2 (enExample) |
| EP (1) | EP3077372B8 (enExample) |
| JP (1) | JP6461960B2 (enExample) |
| KR (1) | KR102251128B1 (enExample) |
| CN (1) | CN105980353B (enExample) |
| AU (1) | AU2014359324B2 (enExample) |
| CA (1) | CA2932483C (enExample) |
| CL (1) | CL2016001364A1 (enExample) |
| CR (1) | CR20160303A (enExample) |
| DK (1) | DK3077372T3 (enExample) |
| DO (1) | DOP2016000125A (enExample) |
| EA (1) | EA030393B1 (enExample) |
| ES (1) | ES2722409T3 (enExample) |
| HR (1) | HRP20190483T1 (enExample) |
| HU (1) | HUE043258T2 (enExample) |
| IL (1) | IL246018B (enExample) |
| LT (1) | LT3077372T (enExample) |
| MX (1) | MX368721B (enExample) |
| MY (1) | MY179106A (enExample) |
| PE (1) | PE20160891A1 (enExample) |
| PH (1) | PH12016501066A1 (enExample) |
| PL (1) | PL3077372T3 (enExample) |
| PT (1) | PT3077372T (enExample) |
| RS (1) | RS58650B1 (enExample) |
| SI (1) | SI3077372T1 (enExample) |
| TN (1) | TN2016000224A1 (enExample) |
| UA (1) | UA117941C2 (enExample) |
| WO (1) | WO2015082533A1 (enExample) |
| ZA (1) | ZA201604043B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3122721A4 (en) * | 2014-03-27 | 2018-01-10 | Piramal Enterprises Limited | Ror-gamma modulators and uses thereof |
| MX2016013518A (es) * | 2014-04-16 | 2017-01-23 | Glenmark Pharmaceuticals Sa | Compuestos de aril y heteroaril eter como moduladores de ror gamma. |
| JOP20200117A1 (ar) | 2014-10-30 | 2017-06-16 | Janssen Pharmaceutica Nv | كحولات ثلاثي فلوروميثيل كمُعدلات للمستقبل النووي جاما تي المرتبط بحمض الريتيونَويك ROR?t |
| RS58250B1 (sr) | 2014-10-30 | 2019-03-29 | Janssen Pharmaceutica Nv | Tiazoli kao modulatori roryt |
| SMT201900706T1 (it) | 2014-10-30 | 2020-01-14 | Janssen Pharmaceutica Nv | Tiazoli sostituiti con ammide come modulatori di rorgammat |
| CN107614062A (zh) | 2015-03-12 | 2018-01-19 | 加利福尼亚大学董事会 | 用RORγ抑制剂治疗癌症的方法 |
| MX394388B (es) | 2015-05-15 | 2025-03-21 | Aurigene Discovery Tech Ltd | Compuestos de tetrahidroquinolinona sustituidos como moduladores de ror gamma |
| WO2016193894A1 (en) * | 2015-05-29 | 2016-12-08 | Glenmark Pharmaceuticals S.A. | Treatment of respiratory disorders using ror- gamma inhibitors |
| EP3101005A1 (en) * | 2015-06-05 | 2016-12-07 | Lead Pharma Cel Models IP B.V. | Ror gamma (rory) modulators |
| EP3101008A1 (en) | 2015-06-05 | 2016-12-07 | Lead Pharma Cel Models IP B.V. | Ror gamma (rory) modulators |
| WO2017010399A1 (ja) * | 2015-07-10 | 2017-01-19 | 塩野義製薬株式会社 | ＲＯＲγｔ阻害作用を有する化合物およびそれらを含有する医薬組成物 |
| CN109071516B (zh) | 2015-12-15 | 2021-08-31 | 阿斯利康(瑞典)有限公司 | 新颖的化合物 |
| TW201803869A (zh) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 作為ＲＯＲγＴ調節劑之６－胺基吡啶－３－基噻唑 |
| TW201815388A (zh) * | 2016-07-14 | 2018-05-01 | 印度商卡迪拉保健有限公司 | 作為ＲＯＲγ調節劑之新穎化合物 |
| BR112019000603A2 (pt) | 2016-07-14 | 2019-04-30 | Cadila Healthcare Limited | composto, composição farmacêutica, método para o tratamento de doenças e uso do composto |
| AR110481A1 (es) * | 2016-12-05 | 2019-04-03 | Lead Pharma Holding Bv | MODULADORES DE ROR g (RORg) |
| WO2018116285A1 (en) * | 2016-12-23 | 2018-06-28 | Glenmark Pharmaceuticals S.A. | Substituted morpholine derivatives as ror gamma modulators |
| WO2018229155A1 (en) | 2017-06-14 | 2018-12-20 | Astrazeneca Ab | 2,3-dihydroisoindole-1-carboxamides useful as ror-gamma modulators |
| US10975037B2 (en) | 2018-06-18 | 2021-04-13 | Janssen Pharmaceutica Nv | Phenyl substituted pyrazoles as modulators of RORγt |
| JP2021527660A (ja) | 2018-06-18 | 2021-10-14 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲγｔのモジュレータとしてのフェニル及びピリジニル置換イミダゾール |
| ES2928246T3 (es) | 2018-06-18 | 2022-11-16 | Janssen Pharmaceutica Nv | 6-aminopiridin-3-il pirazoles como moduladores de RORyt |
| CN112292373A (zh) | 2018-06-18 | 2021-01-29 | 詹森药业有限公司 | 作为RORγt的调节剂的吡啶基吡唑类 |
| EP3921038A1 (en) | 2019-02-06 | 2021-12-15 | Dice Alpha, Inc. | Il-17a modulators and uses thereof |
| WO2021055376A1 (en) | 2019-09-16 | 2021-03-25 | Dice Alpha, Inc. | Il-17a modulators and uses thereof |
| CN112759541B (zh) * | 2019-10-21 | 2023-03-17 | 复旦大学 | 类吲哚衍生物及其用途 |
| TW202136238A (zh) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | RORγt抑制劑及其製備方法和用途 |
| CN113072521B (zh) * | 2020-01-06 | 2024-04-05 | 广东东阳光药业股份有限公司 | RORγt抑制剂及其在药物中的应用 |
| CN114075139B (zh) * | 2020-08-14 | 2025-09-26 | 广东东阳光药业股份有限公司 | 五元杂芳环类化合物及其在药物中的应用 |
| WO2025157313A1 (zh) * | 2024-01-26 | 2025-07-31 | 上海医药集团股份有限公司 | 一种乙磺酰苯基乙酰胺类化合物的晶型、其制备方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011115892A1 (en) | 2010-03-15 | 2011-09-22 | Griffin Patrick R | Modulators of the retinoic acid receptor-related orphan receptors |
| WO2012027965A1 (en) * | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
| WO2013029338A1 (en) * | 2011-09-01 | 2013-03-07 | Glaxo Group Limited | Novel compounds |
| AU2013331493A1 (en) * | 2012-10-16 | 2015-04-09 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORyt |
| WO2013171729A2 (en) | 2013-01-08 | 2013-11-21 | Glenmark Pharmaceuticals S.A. | Aryl and heteroaryl amide compounds as rorgamat modulator |
| RU2015141592A (ru) * | 2013-03-15 | 2017-04-21 | Ф. Хоффманн-Ля Рош Аг | АРИЛ-СУЛЬФАМИДЫ И СУЛЬФАМАТЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ RORc |
| EP2781217A1 (en) * | 2013-03-18 | 2014-09-24 | ETH Zurich | ROR gamma modulators |
-
2014
- 2014-12-03 UA UAA201607189A patent/UA117941C2/uk unknown
- 2014-12-03 CN CN201480074695.6A patent/CN105980353B/zh not_active Expired - Fee Related
- 2014-12-03 KR KR1020167017849A patent/KR102251128B1/ko active Active
- 2014-12-03 MY MYPI2016702008A patent/MY179106A/en unknown
- 2014-12-03 AU AU2014359324A patent/AU2014359324B2/en not_active Ceased
- 2014-12-03 EP EP14809794.2A patent/EP3077372B8/en active Active
- 2014-12-03 CR CR20160303A patent/CR20160303A/es unknown
- 2014-12-03 EA EA201691173A patent/EA030393B1/ru not_active IP Right Cessation
- 2014-12-03 PE PE2016000733A patent/PE20160891A1/es unknown
- 2014-12-03 LT LTEP14809794.2T patent/LT3077372T/lt unknown
- 2014-12-03 MX MX2016007275A patent/MX368721B/es active IP Right Grant
- 2014-12-03 ES ES14809794T patent/ES2722409T3/es active Active
- 2014-12-03 HR HRP20190483TT patent/HRP20190483T1/hr unknown
- 2014-12-03 HU HUE14809794A patent/HUE043258T2/hu unknown
- 2014-12-03 US US15/102,098 patent/US9738600B2/en not_active Expired - Fee Related
- 2014-12-03 PL PL14809794T patent/PL3077372T3/pl unknown
- 2014-12-03 TN TN2016000224A patent/TN2016000224A1/en unknown
- 2014-12-03 RS RS20190494A patent/RS58650B1/sr unknown
- 2014-12-03 JP JP2016536162A patent/JP6461960B2/ja not_active Expired - Fee Related
- 2014-12-03 WO PCT/EP2014/076390 patent/WO2015082533A1/en not_active Ceased
- 2014-12-03 CA CA2932483A patent/CA2932483C/en active Active
- 2014-12-03 DK DK14809794.2T patent/DK3077372T3/en active
- 2014-12-03 PT PT14809794T patent/PT3077372T/pt unknown
- 2014-12-03 SI SI201431174T patent/SI3077372T1/sl unknown
-
2016
- 2016-06-03 CL CL2016001364A patent/CL2016001364A1/es unknown
- 2016-06-03 PH PH12016501066A patent/PH12016501066A1/en unknown
- 2016-06-03 DO DO2016000125A patent/DOP2016000125A/es unknown
- 2016-06-05 IL IL246018A patent/IL246018B/en active IP Right Grant
- 2016-06-14 ZA ZA2016/04043A patent/ZA201604043B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017504576A5 (enExample) | ||
| TWI685491B (zh) | 製備５-（４-環丙基-１ｈ-咪唑-１-基）-ｎ-（６-（４-異丙基-４ｈ-１,２,４-三唑-３-基）吡啶-２-基）-２-氟-４-甲基苯甲醯胺之方法 | |
| RU2351590C2 (ru) | Способ получения диариламина | |
| AU2014359324B2 (en) | ROR gamma (RORy) modulators | |
| JP2016121196A5 (enExample) | ||
| JP6854386B2 (ja) | リゾホスファチジン酸受容体１（ｌｐａｒ１）阻害剤化合物 | |
| JP2008510770A5 (enExample) | ||
| JP2016505058A5 (enExample) | ||
| TW200909400A (en) | Novel sulfonyl malonamide derivative and pharmaceutical use thereof | |
| CN102164898A (zh) | 用于合成卤化的环状化合物的方法 | |
| JP2006517235A5 (enExample) | ||
| JP2011506588A5 (enExample) | ||
| JP2016519165A5 (enExample) | ||
| JP2013521301A5 (enExample) | ||
| JP2019527724A5 (enExample) | ||
| JP2021513982A (ja) | Ｐ３００／ｃｂｐ ｈａｔ阻害剤及びそれらの使用の方法 | |
| JP2002515433A (ja) | 抗ウイルス化合物 | |
| JP2017534653A (ja) | ブロモドメイン及びエキストラ末端タンパク質の阻害のための方法及び組成物 | |
| RU2014145481A (ru) | Циклопропанкарбоксилатные эфиры пуриновых аналогов | |
| JP2016540803A5 (enExample) | ||
| JP2015507004A5 (enExample) | ||
| JP2007505879A (ja) | 既知の抗高脂血症剤の多形体 | |
| WO2012174685A1 (zh) | 一种2-取代-2h-1，2，3-三氮唑衍生物的制备方法 | |
| JP2013541589A5 (enExample) | ||
| ES2965478T3 (es) | Protodescarboxilación catalizada por metales de transición de derivados del ácido alfa-halo-acrílico |